About this file

This is a Notice of Intent to Sole Source and Sole Source Justification document for a federal contract opportunity issued by the Department of Veterans Affairs, Network Contracting Office 23 for the Minneapolis VA Health Care System.

The Department of Veterans Affairs intends to award a sole source Indefinite Delivery (ID) contract to Becton, Dickinson & Company (BD) for the provision of Flow Cytometry Reagents under FAR 6.103-1/FAR 12.102(a), citing that only one responsible source can satisfy agency requirements. The contract will be a 5-year agreement with a base period from October 1, 2026 to September 30, 2027, followed by four additional annual ordering periods through September 30, 2031. The Minneapolis VA Health Care System's Special Hematology Laboratory requires BD-branded flow cytometry reagents that are approved for use exclusively with their owned BD FACSCanto, BD FACSLyric flow cytometers, and BD FACS Lyse Wash Assistants. The extensive list of required reagents includes various antibody-fluorochrome combinations (FITC, PE, PerCP-Cy5.5, PE-Cy7, APC, APC-R700, APC-H7, APC-Cy7, BV421, BV605, and V450 variants), control reagents, calibration beads, and supplies such as sheath fluid, lysing solution, and filter elements. The contract replaces the expiring agreement #36C26324D0048 as of September 30, 2026. The solicitation number is 36C26326R0072, with responses to express interest due by August 20, 2026 at 16:30 CT via email to Contracting Officer Traci Johannes (traci.johannes@va.gov). BD has provided a sole source letter confirming it is the sole manufacturer and distributor of these specific reagents, with no authorized distributors available. Pricing is anticipated to be fair and reasonable based on current contract pricing with allowance for economic inflation.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

VHAPG Part 813.5 Simplified Acquisition Procedures for Certain Commercial Items Attachment 1: Request for Sole Source Justification Template >SAT-SAP under FAR13.5

SUBJECT*
NOTICE OF INTENT TO SOLE SOURCE BD Flow Cytometry Reagents for the Minneapolis VA Health Care System

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
56303
SOLICITATION NUMBER*
36C26326R0072
RESPONSE DATE/TIME/ZONE
08-20-2026 16:30 CENTRAL TIME, CHICAGO, USA
ARCHIVE
14 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6640
NAICS CODE*
325413
PLACE OF PERFORMANCE
Minneapolis VA Health Care System

One Veterans Drive

Minneapolis MN

POSTAL CODE
55417
COUNTRY
USA

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS
DEPARTMENT OF VETERANS AFFAIRS

NETWORK CONTRACTING OFFICE 23

4801 VETERANS DRIVE

SAINT CLOUD MN 56303

POINT OF CONTACT*

Contracting Officer Traci Johannes traci.johannes@va.gov

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
traci.johannes@va.gov
EMAIL DESCRIPTION
Contracting Officer's Email Address

DESCRIPTION

The Department of Veterans Affairs, Network Contracting Office 23 intends to award a sole source contract under the authority of FAR 6.103-1/FAR Overhaul 12.102(a) Only one responsible source and no other supplies or services will satisfy agency requirements to Becton, Dickinson & Company, to provide Flow Cytometry Reagents for the Minneapolis VA.

This notice of intent is not a request for quotations; interested parties may express their interest by providing a capabilities statement no later than August 20th, 2026 at 16:30 CT. The capabilities statement must provide clear and unambiguous evidence to substantiate the capability of the party to provide the required services. A determination not to compete this proposed contract upon responses to this notice is solely within the discretion of the Government. Verbal responses are not acceptable and will not be considered.

When responding to this announcement, respondents should refer to Announcement, Notice of Intent. If after August 20th, 2026 no viable responses have been received in response to this announcement, Department of Veterans Affairs shall negotiate solely with Becton, Dickinson & Company.

This notice of intent to award a sole source contract is not a request for competitive quotes. There will be no solicitation available for competitive quotes. Phone calls will not be accepted.

Presolicitation Notice Presolicitation Notice

All responses must be received by 16:30 PM CST on Thursday, August 20th, 2026.

Responses shall be submitted electronically to Traci Johannes via email at traci.johannes@va.gov. Fax responses and Telephone inquiries will not be accepted.

*=Required Field
Presolicitation Notice

Presolicitation Notice

DEPARTMENT OF VETERANS AFFAIRS

SOLE SOURCE JUSTIFICATION UNDER SIMPLIFIED PROCEDURES FOR CERTAIN COMMERCIAL ITEMS IN ACCORDANCE WITH FAR 13.5

1. Contracting Activity: Department of Veterans Affairs, VISN 23, Minneapolis, MN VA Medical Center

Requiring Activity: Minneapolis VA Health Care System, One Veterans Drive, Minneapolis, MN 55417

2. Nature and/or Description of the Action Being Approved:

5 year Indefinite Delivery Contract with 5 annual Ordering Periods with manufacturer Becton Dickinson (BD)

The effective period of the contract shall be from 10/1/26-9/30/31.

Periods of Performance:

Base Period: 10/1/26 - 9/30/27 Ordering Period 1: 10/1/27 - 9/30/28 Ordering Period 2: 10/1/28 - 9/30/29 Ordering Period 3: 10/1/29 - 9/30/30 Ordering Period 4: 10/1/30 - 9/30/31

3. Description of Supplies/Services Required to Meet the Agency’s Needs:

Schedule of items:

Description
Stock #
Est Annual QTY
Hu CD1a FITC HI149 100Tst
555806
2
CD3 FITC SK7 50 Tests IVD
349201
2
CD8 FITC SK1 ASR
340692
2
CD14 FITC MphiP9 ASR
340682
4
CD15 FITC MMA ASR
340703
2
CD16 FITC NKP15 ASR
340704
1
CD26 FITC (L272) ASR
649456
2
CD33 FITC P67.6 ASR
340678
5
Hu CD43 FITC 1G10 100Tst
555475
8
CD57 FITC HNK-1 ASR
340706
2
CD103 FITC Ber-ACT8 ASR
340944
8
CD158a FITC HP-3E4 50 Tests RUO/GMP
340531
2
Kappa FITC (TB28-2)
643774
20
Anti-TCR-Alpha/Beta-1 FITC WT31 ASR
340883
2
Anti-TdT FITC E17-1519 ASR
347208
2
Ms IgG1 Isotype Control FITC X40 ASR
340755
2
CD5 PE L17F12 ASR
340697
2
CD7 PE M-T701 ASR
340656
5
CD8 PE SK1 IVD
340046
2
CD10 PE HI10a ASR
340920
5
CD14 PE MphiP9 ASR
340683
2
CD22 PE S-HCL-1 ASR
340708
5
CD23 PE EBVCS-5 ASR
341008
8
CD33 PE P67.6 ASR
340679
4
CD56 PE MY31 ASR
340685
2
CD103 PE (Ber-ACT8)
340997
8
Hu CD158B PE CH-L 25Tst
561723
2
Lambda PE (1-155-2)
642924
20
Myeloperoxidase PE 5B8 50 Tests RUO/ GMP
341642
2
Anti-TCR-Gamma/Delta-1 PE 11F2 ASR
340887
2
Mouse IgG1 PE X40 100ug RUO/GMP
349043
2
CD3 PerCP-Cy5.5 SK7 ASR
340948
21
CD8 PerCP-Cy5.5 SK1 ASR
341049
9
CD19 PerCP-Cy5.5 SJ25C1 ASR
340950
18
CD20 PerCP-Cy5.5 L27 ASR
340954
4
CD22 PerCP-Cy5.5 (S-HCL-1)
656311
7
CD33 PerCP-Cy5.5 P67.6 ASR
341640
2
CD34 PerCP-Cy5.5 8G12 ASR
347213
5
CD117 PerCP-Cy5.5 104D2 ASR
333947
4
CD138 PerCP-Cy5.5 MI15 ASR
341097
4
Ms IgG1ItCl PerCP-Cy5.5 X40 ASR
347212
3
CD2 PE-Cy7 L303.1 ASR
335804
3
CD5 PE-Cy7 L17F12 ASR
348800
17
CD8 PE-Cy7 SK1 ASR
335805
5
CD10 PE-Cy7 HI10a ASR
341102
20
CD13 PE-Cy7 L138 ASR
338432
6
CD16 PE-Cy7 B73.1 ASR
335806
3
CD19 PE-Cy7 SJ25C1 ASR
341103
7
CD25 PE-Cy7 (2A3)
335807
8
CD34 PE-Cy7 8G12 ASR
348801
6
CD56 PE-Cy7 NCAM16.2 ASR
335809
15
CD4 APC SK3 ASR
340672
6
CD5 APC (L17F12)
340658
20
CD8 APC SK1 ASR
340659
2
CD11b APC D12 ASR
340936
2
CD11c APC S-HCL-3 ASR
340714
8
CD19 APC SJ25C1 ASR
340722
13
CD20 APC L27 ASR
340940
15
CD23 APC EBVCS-5 ASR
340934
4
CD38 APC HB7 ASR
340677
5
Hu CD43 APC 1G10 100Tst
560198
2
CD103 APC (Ber-ACT8)
563883
5
CD138 APC MI15 ASR
347207
7
Hu CD158e1 (NKB1) APC DX9 100Tst
564103
2
CD200 APC (MRC OX-104) ASR
655428
10
Anti-HLA-DR APC L243 (G46-6) ASR
340691
4
CD19 APC-R700 (SJ25C1)
659112
7
CD23 APC-R700 (EBVCS-5)
659116
7
CD8 APC-H7 (SK1)
641409
10
CD19 APC-H7 (SJ25C1)
643078
14
CD45 APC-Cy7 2D1 ASR
348805
60
CD56 BV421 (NCAM 16.2)
659452
15
CD20 V450 (L27)
642283
15
CD45 V500C (2D1)
647450
60
CD4 BV605 (SK3)
663188
15
CD11c BV605 (B-Ly6)
663799
8
CD200 BV605 (MRC OX-104)
663190
10
Simultest CD3 FITC/CD4 PE SK7/SK31 IVD
340043
8
Anti-Kappa FITC / Anti-Lambda PE
349516
25
BD Multitest 6-Color TBNK w/ Trucount (Lyric)
662995
15
Trucount tubes (only) (Lyric)
340334
2
BD FACSDiva CS&T Research Beads Kit 50T
655050
15
BDTM CS&T IVD Beads (Lyric)
662413
10
BDTM FC Beads 7-Color Kit IVD (Lyric)
662961
2
BDTM FC Beads APC-Cy7 (Lyric)
661622
2
BDTM FC Beads V450 (Lyric)
661623
2
BDTM FC Beads V-500C (Lyric)
661624
2
BDTM FC Beads APC-R700 (Lyric)
661625
2
BDTM FC Beads BV605 (Lyric)
661626
2
BDTM FC Beads BV421 (Lyric)
661627
2
BDTM FC Beads BV510 (Lyric)
661628
2
BDTM FC Beads Dilution Buffer, IVD (Lyric)
661614
1
Ms Ig Kpa Comp Bead Set 6mL
552843
4
BD HorizonTM Brilliant Stain Buffer, 5mL (Lyric)
563794
20
BD FACSFlow Sheath Fluid 20L
342003
60
BD FACS Clean Solution 5L
340345
6
BD FACS Lysing Solution 10X 100ML IVD
349202
15
Lysing Buffer 10X Concentrate 100mL (PharmLyse)
555899
2
Filter Element Sheath Tank (long clean filter)
652531
5
Shipping (cost per order)
NA
30
Sheath Filter Assemby (Lyric filter in machine)
651451
8
Spare Waste Tank Assembly Label/CAP (LWA caps)
335856
3
Shipping per cube of item 342003 ( Sheath Fluid 20L)
NA
60

4. Statutory Authority Permitting Other than Full and Open Competition:

( X ) (1) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by RFO 6.103-1;

( ) (2) Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by RFO 6.103-2;

( ) (3) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services per 41 USC §3304(a)(3) as implemented by RFO 6.103-3;

( ) (4) International Agreement per 41 USC §3304(a)(4) as implemented by RFO 6.103-4 ( ) (5) Authorized or Required by Statute per 41 USC §3304(a)(5) as implemented by RFO 6.103-5;

( ) (6) National Security per 41 USC §3304(a)(6) as implemented by RFO 6.103-6;

( ) (7) Public Interest per 41 USC §3304(a)(7) as implemented by RFO 6.103-7;

5. Demonstration that the Contractor’s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): The Minneapolis VA Health Care System Special Hematology Laboratory needs to establish a 5-year contract which provides a variety of Becton Dickinson (BD) brand name flow cytometry reagents which are approved for use with our owned BD FACSCanto™ and BD FACSLyric™ flow cytometers and on our owned BD FACS™ Lyse Wash Assistants. These reagents are used to perform clinical immunophenotyping testing for diagnostic and prognostic patient care at the MVAHCS and are the only ones approved for use on our owned BD FACSCanto™ and BD FACSLyric™ flow cytometers and on our owned BD FACS™ Lyse Wash Assistants. These reagents are manufactured and distributed solely by BD therefore a sole source procurement is required. Our existing contract # 36C26324D0048 which supports these items expires 9/30/26.

The manufacturer has provided a sole source letter which states that they are the sole manufacturer and distributor of these reagents. There are no authorized distributors.

6. Description of Efforts Made to ensure that offers are solicited from as many potential sources as possible (including whether a notice was or will be publicized as required by RFO Part 5 and, if not, which exception under RFO Part 5 applies): There is only one source that will satisfy the requirements. BD provided a sole source letter indicating that they are the sole manufacturer and distributor of the specific reagents that our laboratory has approved for use and is requesting in this requirement. A notice of intent to sole source will be posted on SAM.gov to confirm this.

7. Determination by the CO that the Anticipated Cost to the Government will be Fair and Reasonable: Pricing is anticipated to be fair and reasonable based off of the current IDC pricing for the Minneapolis VA that ends on 09/30/2026.The IGCE for this procurement does account for economic inflation and falls in line for the proposed quote of usage. Testing volume continues to rise for this contract due to performing validations on the new flow cytometry equipment within the fleet of analyzers but does not impact the price per reagent, only increased usage.

8. Description of the Market Research Conducted and the Results, or a Statement of the Reasons Market Research Was Not Conducted: SBA was searched using NAICS 325413 – 123 SDVOSB results returned. Government mandatory contracts were searched, none available with the specified reagents. A sole source letter was provided at the time of quote stating that BD is the sole source to obtain these reagents for the intended analyzers. A Notice of Intent to sole source will be posted to SAM.gov to confirm this.

9. Any Other Facts Supporting the Use of Other than Full and Open Competition:

NA

10. Listing of Sources that Expressed, in Writing, an Interest in the Acquisition:

Becton Dickinson Anna Jackson Contract Consultant, Government Contracting 619-657-0288

11. A Statement of the Actions, if any, the Agency May Take to Remove or Overcome any Barriers to Competition before Making subsequent acquisitions for the supplies or services required: Our laboratory will continue to evaluate our flow cytometry reagent needs. Currently all cytometry equipment in the laboratory is owned and BD manufacturers the proprietary reagents which are used to operate this equipment and presently validated in our laboratory. When it comes time to replacing the flow cytometry equipment, we will evaluate reagents options on the market as well.

12. Requirements Certification: I certify that the requirement outlined in this justification is a Bona Fide Need of the Department of Veterans Affairs and that the supporting data under my cognizance, which are included in the justification, are accurate and complete to the best of my knowledge and belief.

13. Approvals in accordance with the VHAPM Part 806.3 OFOC SOP:

a. Contracting Officer Certification (required): I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.

Traci Johannes Date Contracting Officer Network Contracting Office 23

Effective Date: 12/30/25 Page 9 of 9 Revision: 02

File details come from the government source that posted it. Updated .